Monday - December 23, 2024

Cellular Immunotherapy for Repetitive Administration

2024-11-19

ALEXANDRIA, Virginia, Nov. 19 -- CELLECTIS, Paris, France has been assigned a patent (No. US 12144825 B2, initially filed July 2, 2018) developed by six inventors David Sourdive, Levallois-Perret, France; Aymeric Duclert, St Maur des Fosses, France; Mathieu Simon, Paris, France; Philippe Duchateau, Draveil, France; Alan Marc Williams, New York, New York; and Laurent Poirot, Paris, France, for "Cellular immunotherapy for repetitive administration." . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

Cellular Immunotherapy for Repetitive Administration

Information Request Form

Copyright Targeted News Service 2024